Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Solaiman Shereen, holds the title of Chief People Officer at MYRIAD GENETICS INC.
On 2026-11-06, the insider transacted 83,049 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Solaiman Shereen (Chief People Officer) was granted $0 of $MYGN
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.